Rate My Professor Bruce King

Professor Bruce King serves as Conjoint Professor in the School of Medicine and Public Health, College of Health, Medicine and Wellbeing, at the University of Newcastle. He earned his Doctor of Philosophy from the University of Newcastle and his Bachelor of Medicine and Bachelor of Surgery from the University of Queensland. Currently, he is also a Staff Specialist in Paediatric Endocrinology at John Hunter Hospital, where he applies his expertise in managing complex cases of childhood endocrine disorders.

Professor King's academic interests lie in biomolecular chemistry, medicinal chemistry, and paediatric endocrinology, with a particular emphasis on type 1 diabetes mellitus. His research explores the impacts of dietary protein and fat on postprandial glucose levels, optimal insulin bolusing strategies for mixed meals, the role of continuous glucose monitoring and hybrid closed-loop systems in adolescents, and glycaemic responses to different exercise types in youth with type 1 diabetes. He has made significant contributions through high-impact publications, such as Both Dietary Protein and Fat Increase Postprandial Glucose Excursions in Children With Type 1 Diabetes, and the Effect Is Additive published in Diabetes Care in 2013, which demonstrated the additive effects of protein and fat on glucose excursions. In 2015, his paper Impact of Fat, Protein, and Glycemic Index on Postprandial Glucose Control in Type 1 Diabetes: Implications for Intensive Diabetes Management in the Continuous Glucose Monitoring Era in the same journal highlighted key nutritional factors influencing glycaemic control. More recently, in 2025, A Comparison of Glucose and Additional Signals for Three Different Exercise Types in Adolescents with Type 1 Diabetes Using a Hybrid Closed-Loop System addressed exercise management. Other notable works include Influence of dietary protein on postprandial blood glucose levels in individuals with Type 1 diabetes mellitus using intensive insulin therapy (Diabetic Medicine, 2016) and Effectiveness of a Predictive Algorithm in the Prevention of Exercise-Induced Hypoglycemia in Type 1 Diabetes (Diabetes Technology & Therapeutics, 2016). Earlier research includes investigations into corticotropin-releasing hormone gene expression regulation (e.g., Frontiers in Bioscience, 2007). Through these efforts, Professor King has advanced clinical guidelines and technological applications for paediatric diabetes care, improving outcomes for young patients globally.